Hydralazine injection labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 41: | Line 41: | ||
{| | {| | ||
| [[image:hydra10. | | [[image:hydra10.jpg|400px|thumb]] | ||
|} | |} | ||
Revision as of 06:35, 11 March 2014
Hydralazine |
---|
HYDRALAZINE tablet® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings |
Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
How Supplied/Storage and Handling |
Labels and Packages |
HYDRALAZINE injection® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings |
Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
How Supplied/Storage and Handling |
Labels and Packages |
Clinical Trials on Hydralazine |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Label
NDC 63323-614-55
NP601401
hydrALAZINE HYDROCHLORIDE INJECTION, USP 20 mg/mL
FOR IM OR IV USE
1 mL Rx only
Single Dose Vial WARNING: DISCARD UNUSED PORTION.
PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Tray Label NDC 63323-614-55
NP601401
hydrALAZINE HYDROCHLORIDE INJECTION, USP
FOR INTRAMUSCULAR OR INTRAVENOUS USE
20 mg/mL
1 mL Single Dose Vial
N+ and NOVAPLUS are registered trademarks of Novation, LLC
Rx only
References
- ↑ "HYDRALAZINE HYDROCHLORIDE INJECTION [FRESENIUS KABI USA, LLC]". Retrieved 10 March 2014.